abstract |
The invention relates to compounds of formula (I) wherein D, R 1 , R 2 , R 3 and R 4 are defined as in claim 1. The compounds according to the invention are tyrosine kinase inhibitors, especially Met kinase inhibitors and can be used, inter alia, to treat tumors. |